August 2011
Contents
Editorial
Special reports
Conference reports
- 18th Conference on Retroviruses and Opportunistic Infections (CROI) 27 February–3 March 2011, Boston
- Treating children previously exposed to single dose nevirapine: update on IMPAACT P1060 and NEVEREST
Antiretrovirals
- FDA approve new NNRTI-based fixed dose combination of rilpivirine/tenofovir/FTC (Complera) in the US